GANX
Gain Therapeutics Inc
1.80$
-3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.0% | +0.0% | +0.0% | +100.4% | 0.0% | +0.0% | +0.0% | – | – | -4.5% | +5.1% | +36.5% | -42.3% | +1,592.4% | -69.3% | +58.0% | +4.2% | +111.3% | -100.0% | – | -60.6% | -100.0% | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -2.6% | +128.2% | +45.7% | +26.2% | +38.1% | -40.5% | +5.7% | +65.9% | -23.9% | -99.1% | +15,119.8% | -91.1% | +2.5% | -90.6% | +10,375.8% | +78.2% | -93.7% | -92.3% | +10,333.7% | +22.5% | -99.2% | -21,462.0% | – | – | – | |
| – | – | +0.0% | +0.0% | – | – | +0.0% | +0.0% | – | – | -4.5% | +5.1% | +36.5% | -42.3% | +1,592.4% | -69.3% | +58.0% | +4.2% | +111.3% | -2,166.0% | – | – | -542.9% | – | – | – | – | – | – | – | – | – | – | -100.4% | – | – | |
| – | +0.0% | +0.0% | +0.0% | +91.8% | 0.0% | +0.0% | +0.0% | +33.5% | -21.2% | +5.2% | -2.6% | +128.2% | +45.7% | +26.2% | +38.1% | -40.5% | +5.7% | +65.9% | -23.9% | +15.7% | +22.8% | +42.9% | -40.6% | +0.3% | +5.6% | +77.0% | -40.9% | -53.3% | +84.3% | +22.2% | +3.3% | -17.6% | +17.7% | -22.6% | – | |
| – | 0.0% | +0.0% | +0.0% | +150.0% | 0.0% | +0.0% | +0.0% | +59.7% | -54.1% | -1.7% | +298.4% | +63.0% | +61.9% | +72.3% | +20.8% | -18.6% | -0.1% | +51.3% | +3.6% | -17.9% | +9.0% | +50.1% | -32.7% | -19.2% | -8.0% | +100.2% | -50.9% | +14.6% | +0.3% | +10.3% | -16.9% | +9.4% | +22.3% | -1.8% | – | |
| – | – | – | – | – | – | – | – | – | -25.3% | +3.8% | +53.3% | +96.8% | +52.2% | +45.8% | +29.4% | -30.3% | +2.5% | +58.1% | -9.9% | -4.0% | +15.9% | +46.3% | -36.8% | -9.8% | -0.7% | +86.9% | -45.5% | -25.3% | +31.2% | +16.5% | -6.0% | -6.7% | +19.9% | -12.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +73.3% | -13.2% | -99.5% | – | – | +319.1% | -16.7% | – | – | +3,528.0% | +156.0% | +38.0% | -28.1% | -14.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | +0.0% | +0.0% | -27.3% | +0.0% | +0.0% | +0.0% | -0.1% | -24.2% | +235.8% | -80.4% | -254.6% | – | +5.2% | +39.7% | -261.2% | – | +445.4% | -55.7% | +1,829.5% | -78.6% | +58.9% | -19.3% | -32.4% | +37.0% | -93.9% | +809.3% | +4,491.0% | -80.1% | +40.5% | +289.0% | -87.2% | +161.1% | -43.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | +0.0% | -294,804.5% | – | +0.0% | +0.0% | -108,067.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.